NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...
Researchers at the Institute for Molecular Science (NINS, Japan) and SOKENDAI have demonstrated a more than 2000% voltage-induced enhancement of near-field nonlinear optical responses. To achieve this ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod in NCP. NCP is a chronic ocular pain syndrome with no FDA-approved therapies ...
MedPage Today on MSN
Renowned physician dies; coffee and mood modulation; maternal syphilis soars
Health news and commentary gathered by MedPage Today staff ...
Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of immunomodulatory activity ...
Abstract: High-phase-count machines are well known to have reduced dc bus utilization compared to conventional three-phase drives. High-phase-count machines for fault tolerance and variable-pole ...
Abstract: In the field of constant envelope orthogonal frequency division multiplexing (CE-OFDM), the use of phase modulation heralds a paradigm with an extremely reduced peak-to-average power ratio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results